Clinical trial

Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With…

NCT00085774 · Teva Branded Pharmaceutical Products R&D, Inc., Industry · Completed

Key facts

NCT number NCT00085774
Title Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
Official title A Single-Dose Efficacy Comparison of Albuterol Hydrofluoroalkane (HFA) Breath-operated Inhaler (BOI) (Volare Easi-Breathe™) and Albuterol HFA Meter Dose Inhaler (MDI) (Volare™) in Adolescents and Adults With Exercise-Induced Bronchospasm
Lead sponsor Teva Branded Pharmaceutical Products R&D, Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Exercise-induced Bronchospasm
Intervention type Drug
Interventions albuterol aerosol by HFA MDI, albuterol aerosol by HFA BOI, placebo aerosol by HFA
Enrollment 24
Start date Jun 30, 2004
Primary completion Sep 30, 2004
Completion Sep 30, 2004
First posted Jun 17, 2004
Last update posted Nov 24, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies